112 filings
Page 6 of 6
8-K
cm81jfmlal
3 Nov 16
CytomX Therapeutics Announces Third Quarter 2016 Financial Results and Provides Pipeline Update
12:00am
8-K
fjxsss3 h4eo26
3 Aug 16
CytomX Announces Second Quarter 2016 Financial Results
12:00am
8-K
0175x
13 Jun 16
CytomX Therapeutics Appoints John A. Scarlett, M.D., to Board of Directors
12:00am
8-K
8qdd2rs57bz vgfhpxcl
6 May 16
CytomX Announces First Quarter 2016 Financial Results
12:00am
8-K
gsx0zjkaj yqb7px5i
28 Apr 16
Departure of Directors or Certain Officers
12:00am
8-K
na0x23paxguokxlmgjs
21 Apr 16
CytomX and AbbVie Announce Strategic Collaboration for Probody Drug Conjugates
12:00am
8-K
0f247zhch u56pzsgxx
7 Mar 16
CytomX Announces Year-End 2015 Financial Results
12:00am
8-K
plby8b lb4d78
22 Feb 16
Regulation FD Disclosure
12:00am
8-K
72x1g2
20 Jan 16
CytomX Announces Third Target Selection by Bristol-Myers Squibb, Triggering Milestone
12:00am
8-K
szocn2 afx
16 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
74jlwva
23 Nov 15
CytomX Reports Third Quarter 2015 Financial Results
12:00am
8-K
inq0dmrza
19 Oct 15
Amendments to Articles of Incorporation or Bylaws
12:00am